| Name: | Bortezomib Hydroxy Impurity |
| Catalogue No. | VE006536 |
| CAS No. | N/A |
| Molecular Formula | C19H24N4O3 |
| Molecular Weight | 356.42 |
| Status | In-stock |
| IUPAC Name | Pyrazine-2-carboxylic acid [1-(1-hydroxy-3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-amide |
| Description | Bortezomib Hydroxy Impurity or Pyrazine-2-carboxylic acid [1-(1-hydroxy-3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-amide is associate impurity of Bortezomib. Bortezomib is a proteasome inhibitor and antineoplastic agent that's employed in treatment of refractory myeloma and bound lymphomas. |
| References | “Sci-Hub | Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling | 10.1155/2015/172458.” Hkvisa.net, 2015, sci-hub.hkvisa.net/10.1155/2015/172458. |
